Moreover, Previous study has reported TGFBR2 inhibitor as a potent drug for pancreatic cancer treatment, the TGFBR2 inhibitor, Galunisertib significantly improved overall survival in patients with unresectable pancreatic cancer [31]. Here, TGFBR2 is linked to pancreatic neoplasm.